Provides a pathogen-by-pathogen accounting of weapons agents, considering their weapons use/potential and contextualizing that with typical medical microbiology and epidemiology background information.
This report makes recommendations to the Department of Defense about how to accelerate research and development towards countermeasures against bioterrorism, under the assumption that it poses a threat.
Also known as the Fink Report, presented findings of the Committee on Research Standards and Practices to Prevent the Destructive Application of Biotechnology, which investigated the risks of misuse of biotechnology research.
Description of transmission routes/pathways for grouping infectious diseases broadly (food- and water-borne, contact, air-borne, vector-borne, endogenous). Criteria for selection of infective agents that pose biological warfare risk. Rules out a list…
Evaluates possibility of BW in response to public interest/concern. Reviews practical limitations to development and use of biological weapons. Covers Intestinal Disease, Respiratory Disease, Insect-Transmitted Disease, Infective (Non-Communicable)…
This is the third edition of Medical Aspects of Biological Warfare and aims to highlight the current state of science on individual agents and toxins and general response capabilities to prevent knowledge gaps and serve as a reference source for the…
This report is an historical analysis of US biodefense and bioweapons posture in order to understand the disparity between chemical weapons preparedness and biological weapons preparedness.
This hearing before the Subcommittee on Intelligence, Emerging Threats, and Capabilities discussed the threat of biological weapons attacks from state and nonstate actors.